Davenport & Co’s Eli Lilly LLY Stock Holding History

Davenport & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.8M	Buy	40,627 +914	+2%	+$934K	0.24%	118
2026 Q1	$36.4M	Buy	39,713 +1,822	+5%	+$1.85M	0.2%	120
2025 Q4	$40.7M	Buy	37,891 +3,753	+11%	+$3.59M	0.22%	112
2025 Q3	$25.9M	Buy	34,138 +2,080	+6%	+$1.55M	0.14%	135
2025 Q2	$25M	Sell	32,058 -1,214	-4%	-$943K	0.14%	141
2025 Q1	$27.5M	Buy	33,272 +61	+0.2%	+$50.8K	0.16%	136
2024 Q4	$25.6M	Buy	33,211 +944	+3%	+$782K	0.14%	137
2024 Q3	$28.6M	Buy	32,267 +778	+2%	+$699K	0.16%	135
2024 Q2	$28.5M	Buy	31,489 +162	+0.5%	+$130K	0.17%	130
2024 Q1	$24.4M	Buy	31,327 +291	+0.9%	+$207K	0.15%	144
2023 Q4	$18.1M	Sell	31,036 -466	-1%	-$272K	0.12%	147
2023 Q3	$16.9M	Sell	31,502 -1,513	-5%	-$780K	0.13%	143
2023 Q2	$15.5M	Sell	33,015 -1,344	-4%	-$564K	0.11%	145
2023 Q1	$11.8M	Buy	34,359 +879	+3%	+$296K	0.09%	167
2022 Q4	$12.3M	Buy	33,480 +753	+2%	+$267K	0.1%	156
2022 Q3	$10.6M	Buy	32,727 +1,245	+4%	+$394K	0.09%	159
2022 Q2	$10.2M	Sell	31,482 -104	-0.3%	-$31.2K	0.08%	167
2022 Q1	$9.05M	Buy	31,586 +3,129	+11%	+$805K	0.06%	191
2021 Q4	$7.86M	Sell	28,457 -13	-0%	-$3.3K	0.05%	205
2021 Q3	$6.58M	Sell	28,470 -45	-0.2%	-$11.1K	0.05%	212
2021 Q2	$6.54M	Buy	28,515 +1,411	+5%	+$283K	0.05%	195
2021 Q1	$5.06M	Buy	27,104 +2,174	+9%	+$425K	0.05%	195
2020 Q4	$4.21M	Sell	24,930 -881	-3%	-$132K	0.04%	197
2020 Q3	$3.82M	Sell	25,811 -154	-0.6%	-$23.8K	0.04%	181
2020 Q2	$4.26M	Sell	25,965 -178	-0.7%	-$27.3K	0.05%	163
2020 Q1	$3.63M	Sell	26,143 -468	-2%	-$64.3K	0.05%	168
2019 Q4	$3.5M	Sell	26,611 -2,028	-7%	-$235K	0.04%	202
2019 Q3	$3.17M	Buy	28,639 +660	+2%	+$73.5K	0.04%	195
2019 Q2	$3.1M	Sell	27,979 -1,643	-6%	-$193K	0.04%	196
2019 Q1	$3.84M	Buy	29,622 +160	+0.5%	+$19.5K	0.05%	185
2018 Q4	$3.41M	Buy	29,462 +1,675	+6%	+$187K	0.05%	180
2018 Q3	$2.98M	Sell	27,787 -1,383	-5%	-$138K	0.03%	204
2018 Q2	$2.49M	Buy	29,170 +109	+0.4%	+$8.95K	0.03%	215
2018 Q1	$2.25M	Buy	29,061 +186	+0.6%	+$15K	0.03%	216
2017 Q4	$2.44M	Sell	28,875 -1,134	-4%	-$96.5K	0.03%	211
2017 Q3	$2.57M	Buy	30,009 +552	+2%	+$45.3K	0.03%	192
2017 Q2	$2.42M	Sell	29,457 -5,890	-17%	-$481K	0.03%	189
2017 Q1	$2.6M	Sell	35,347 -500	-1%	-$40K	0.04%	190
2016 Q4	$2.64M	Buy	35,847 +2,856	+9%	+$213K	0.04%	183
2016 Q3	$2.65M	Buy	32,991 +463	+1%	+$37.1K	0.04%	177
2016 Q2	$2.56M	Buy	32,528 +4,002	+14%	+$301K	0.04%	184
2016 Q1	$2.05M	Sell	28,526 -10,324	-27%	-$781K	0.03%	201
2015 Q4	$3.27M	Buy	38,850 +10,730	+38%	+$890K	0.05%	166
2015 Q3	$2.35M	Buy	28,120 +1,245	+5%	+$105K	0.04%	186
2015 Q2	$2.24M	Sell	26,875 -1,200	-4%	-$91.4K	0.03%	201
2015 Q1	$2.04M	Sell	28,075 -1,550	-5%	-$110K	0.03%	222
2014 Q4	$2.04M	Sell	29,625 -2,700	-8%	-$182K	0.03%	214
2014 Q3	$2.1M	Sell	32,325 -900	-3%	-$57K	0.04%	206
2014 Q2	$2.07M	Buy	33,225 +1,023	+3%	+$61K	0.04%	202
2014 Q1	$1.9M	Sell	32,202 -522	-2%	-$29.1K	0.03%	204
2013 Q4	$1.67M	Buy	32,724 +102	+0.3%	+$5.11K	0.03%	203
2013 Q3	$1.64M	Buy	32,622 +25	+0.1%	+$1.31K	0.03%	193
2013 Q2	$1.6M	Buy	+32,597	New	+$1.77M	0.04%	184

Other funds holding LLY

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Davenport & Co's LLY Position: Q2 2026 in Review

Davenport & Co increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $934K and bringing the position to 40,627 shares worth $48.8M. The position accounts for 0.24% of the portfolio, ranked #118.

Davenport & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 988 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Davenport & Co held 40,627 shares of Eli Lilly worth $48.8M as of Q2 2026.
Davenport & Co bought 914 Eli Lilly shares in Q2 2026, an estimated $934K.
Eli Lilly made up 0.24% of Davenport & Co's portfolio in Q2 2026, its #118 holding.
Davenport & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
988 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.